|
Case
|
Gender/age
|
Etiology
|
HAIC cycle
|
AFP (initial-preoperative)
|
Bilobar HCC
|
PVTT
|
Extrahepatic metastasis
|
Resection
|
Margin
|
Recurrence (time/site) (months)
|
Survival time (months)
|
|---|
|
1
|
F/73
|
HBV
|
6
|
3170–99.4
|
No
|
Yes
|
Yes (LNs)
|
Minor
|
Tumor-free
|
No
|
81
|
|
2
|
M/44
|
HBV
|
6
|
5845–2.8
|
No
|
Yes
|
No
|
Major
|
Tumor-free
|
No
|
120
|
|
3
|
M/61
|
HBV
|
8
|
11.74–8.8
|
No
|
Yes
|
No
|
Major
|
Tumor-free
|
18/lung
|
46
|
|
4
|
M/40
|
HBV
|
4
|
158.0–432.2
|
No
|
Yes
|
No
|
Major
|
Tumor-free
|
2/liver
|
18
|
|
5
|
M/42
|
HBV
|
6
|
950–60.2
|
No
|
Yes
|
No
|
Major
|
Tumor-free
|
13/lung
|
31
|
|
6
|
M/53
|
HBV
|
4
|
369.9–337.7
|
No
|
Yes
|
No
|
Major
|
Tumor-free
|
2/liver
|
10
|
|
7
|
F/48
|
HBV
|
6
|
188663–40762
|
Yes
|
No
|
No
|
Minor
|
Tumor-free
|
3/liver
|
37
|
|
8
|
M/44
|
HBV
|
7
|
7.5–6.7
|
Yes
|
Yes
|
No
|
Minor
|
Tumor-free
|
10/liver
|
33
|
|
9
|
M/56
|
HBV
|
3
|
911.6–23.1
|
No
|
Yes
|
No
|
Major
|
Tumor-free
|
47/liver
|
68
|
|
10
|
M/47
|
HBV
|
6
|
1038–701.1
|
Yes
|
No
|
No
|
Major
|
Tumor-free
|
13/liver, lung
|
43
|
|
11
|
F/39
|
HBV
|
8
|
121000–6047
|
Yes
|
Yes
|
No
|
Major
|
Tumor-involved
|
7/liver
|
20
|
|
12
|
M/46
|
HBV
|
6
|
188.6–17.2
|
Yes
|
Yes
|
No
|
Minor
|
Tumor-free
|
3/liver
|
67
|
- HAIC hepatic arterial infusion chemotherapy, HBV hepatitis B, AFP alpha-fetoprotein, HCC hepatocellular carcinoma, PVTT portal vein tumor thrombus, LN lymph node
